(EVFM) – Management Comments
-
Evofem Biosciences (EVFM) Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate
-
Evofem Biosciences (EVFM) Misses Q4 EPS by 14c
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EVFM Stock Lookup